Cargando…
Leprosy stigma & the relevance of emergent therapeutic options
Autores principales: | Sardana, Kabir, Khurana, Ananta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055175/ https://www.ncbi.nlm.nih.gov/pubmed/32134008 http://dx.doi.org/10.4103/ijmr.IJMR_2625_19 |
Ejemplares similares
-
A Pilot Analysis of Morphometric Assessment of Itraconazole Brands Using Dermoscopy and its Relevance in the Current Scenario
por: Sardana, Kabir, et al.
Publicado: (2018) -
Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences
por: Saxena, Snigdha, et al.
Publicado: (2021) -
Cyclophosphamide in a Recalcitrant Case of Nekam’s Disease
por: Muddebihal, Aishwarya, et al.
Publicado: (2023) -
Which is the Ideal JAK Inhibitor for Alopecia Areata – Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway
por: Sardana, Kabir, et al.
Publicado: (2023) -
Sepsis assessment in SJS/TEN: an important point overlooked?()()
por: Khurana, Ananta, et al.
Publicado: (2019)